PubMed · 7186982
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
E Masuhara, Y Kadoma. 1982. [Biomaterials].. https://pubmed.ncbi.nlm.nih.gov/7186982/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
The methodology and one of the first attempts to produce transmission electron microscopic (TEM) specimens of nanocrystalline metals, alloys and ceramics by ultramicrotomy are presented. Samples of the pure elements Co, Pd; alloys of Y-12 at. % Fe, Al-7 at. % Ag and W-30 at. % Ga; and ZnO ceramic, were found to section successfully to varying degrees. Advantages of sections prepared through ultramicrotomy over ion beam methods include extensive electron-transparent regions of uniform thickness and absence of ion beam damage. Typical artefacts were observed (knife marks, tearing, pull-out, shear lamellae, section curling, and anodic dissolution) but did not impede TEM analysis significantly. A potentially important effect observed was that of a texture development upon sectioning of the Co and Pd samples. It is thought that this unusual phenomenon results from the extremely fine scale of the microstructure and the purity of the Co and Pd samples, and may be enhanced by frictional heating effects and the state of the knife edge.
A recent advance in metallurgical technology has been the application of rapid solidification techniques to Al alloy production. FVS0812 is the designation given to a microcrystalline Al-based alloy consisting of 8 wt% Fe, 1 wt% V and 2 wt% Si. It is a two-phase alloy, consisting of ca. 27 vol percent of approximately spherical Fe-V-Si-rich dispersoids in an essentially pure Al matrix. The high strength, low density properties of this advanced material, and other related alloys, have not yet been realized, however, due, in part, to the inability of the alloy to form a thick, adherent, abrasion-resistant outer surface oxide film, a feature readily achieved at conventional Al alloys by normal anodizing methods. The present research has involved an electro-chemical study of oxide film growth at the 812 alloy, with the specific goals being to seek an understanding of the origin of the oxide film growth problem and ultimately to propose alternative approaches to the formation of a thick, stable oxide film at this material. The techniques used in this research have included electrochemical methodologies such as cyclic voltammetry and electrochemical impedance spectroscopy. Crucial information has been obtained through transmission electron microscopy (TEM) of ultramicrotomed specimens. Experiments were carried out initially in neutral borate solutions to characterize the compact barrier oxide film formed in this environment and expected to be present beneath the porous oxide film formed in the normal sulfuric acid anodizing medium.(ABSTRACT TRUNCATED AT 250 WORDS)
Polymer-coated removable stents were used to deliver 14C-labeled etretinate and 3H-labeled forskolin to the vessel wall in 31 New Zealand White rabbits to study their kinetics. Stents loaded with etretinate (n = 8) and forskolin (n = 14) were implanted in the rabbit carotid arteries, and the animals were euthanized at different time intervals. Drug levels were measured in the media and adventitia of the stented segment, in distant tissues, and in blood. In four rabbits, forskolin-loaded stents were percutaneously retrieved 2 hr after implantation in the carotid artery, and the tissue and blood levels were determined 2 and 24 hr after retrieval. In seven rabbits etretinate-loaded stents were retrieved 72 hr after implantation in abdominal aorta, and drug levels were measured in the tissues and blood immediately after and at 1 and 4 days after retrieval. Levels of etretinate in the vessel wall peaked at 24 hr (250 ng/mg) and remained high up to 72 hr (185 ng/mg) after stent placement. Levels of forskolin peaked within 2 hr of stent placement (135 ng/mg) and rapidly declined to 4.9 ng/mg at 24 hr with the stent in situ. About 50% (1.4 mg) of the original etretinate remained in the stent at 72 hr compared to about 5% (0.08 mg) of forskolin at 24 hr. Ratio of peak drug levels in the vessel wall to those in the blood was 6,000 for etretinate and 780 for forskolin. (ABSTRACT TRUNCATED AT 250 WORDS)